BioAge Labs BIOA
NASDAQ BIOA
$9.69 -1.06 (-9.86%)
At close: Aug 20, 2026 · 1:42 PM UTC

BioAge Labs (BIOA) Shares Outstanding (Entity) (2023 - 2026)

BioAge Labs (BIOA) Shares Outstanding (Entity) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - 4.44 Bn
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn 1.17 Bn
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn 414.15 Mn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn -
5 United Therapeutics 22.19 Bn 19.53 Bn 683.80 Mn 42.68 Mn
6 Viatris 18.68 Bn 17.79 Bn 1.46 Bn 1.15 Bn
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn 101.60 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 499.55 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - 834.66 Mn
10 BioAge Labs 434.49 Mn 434.49 Mn -14.23 Mn 45.78 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 45.90 Mn
Mar 31, 2026 44.39 Mn
Dec 31, 2025 37.39 Mn
Sep 30, 2025 35.85 Mn
Jun 30, 2025 35.85 Mn
Mar 31, 2025 35.85 Mn
Dec 31, 2024 10.73 Mn
Sep 30, 2024 3.49 Mn
Jun 30, 2024 1.72 Mn
Mar 31, 2024 1.67 Mn
Dec 31, 2023 1.67 Mn
Sep 30, 2023 1.67 Mn